Within this review, we will assess the existing understanding of how five specific TRP channels (TRPA1, TRPC5, TRPV1, TRPV2, and TRPM2) contribute to the resistance of breast cancer to therapeutic interventions. Here, TRPM2 is linked to breast carcinoma.